Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi‐institutional randomized controlled trial

Oral mucositis is a common and distressing complication in patients receiving high‐dose chemotherapy followed by hematopoietic stem cell transplantation (HSCT). We reported previously in a single‐center retrospective analysis that zinc‐L‐carnosine (polaprezinc [PZ]) reduced the incidence of oral muc...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of cancer 2021-03, Vol.148 (6), p.1462-1469
Hauptverfasser:	Kitagawa, Junichi, Kobayashi, Ryo, Nagata, Yasuyuki, Kasahara, Senji, Ono, Takaaki, Sawada, Michio, Ohata, Koichi, Kato‐Hayashi, Hiroko, Hayashi, Hideki, Shimizu, Masahito, Itoh, Yoshinori, Tsurumi, Hisashi, Suzuki, Akio
Format:	Artikel
Sprache:	eng
Schlagworte:	Cancer Carnosine Chemotherapy hematopoietic stem cell transplantation Hematopoietic stem cells Medical research Mucositis oral mucositis polaprezinc Prevention Prophylaxis Stem cell transplantation Stem cells
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!